Cecilia Pozzi
SEEK ID: https://fairdomhub.org/people/2256
Location:
Italy
ORCID:
https://orcid.org/0000-0003-2574-3911
Joined: 25th Oct 2022
Expertise: structural biology, Cancer research, parassite research, drug development, antibiotic resistance, drug resistance, antibacterial drugs, neurodegenerative diseases, metalloproteins, protein-protein interactions, protein production
Tools: X-ray crystallography, Protein chemical methods (protein overproduction, recombinant technology, recombinant protein production, Site-directed mutagenesis, Spectroscopy and structural analysis
Their tagsRelated items
The recent COVID19 pandemic infection has undisclosed long-standing issues in the translation of drugs from animals to humans or vice-versa. Nearly 75% of emerging human infections worldwide originated from animals; existing drugs for human and animal (H&A) vector-borne diseases (VBD) are scarce, with limited efficacy, toxicity, and finite resources. Emerging environmental problems in pharmaceutical use/manufacturing increase attention in the field. The two drug pipelines are developed ...
Projects: WG1 - Compound libraries coordination and integration of compound design, WG2 - Integration of early phase studies and low environmental impact actions, WG3 - Coordination of in vitro-to-in vivo translation of OneHealth leads and candidates, WG4 - Integration of R&D process-environmental studies and translation in informed whitepaper, WG5 - Promote dissemination, WG6 - Promote the transfer of knowledge
Web page: https://onehealthdrugs.com/
Public web page: Not specified
Public web page: Not specified
Public web page: Not specified
Public web page: Not specified
